Carotid Artery Disease News and Research

RSS
Approximately one-fourth of all strokes are caused by carotid artery disease, a condition wherein one or both carotid arteries in the neck become blocked by plaque, which can break off and cause stroke. Traditional surgical treatment for carotid artery disease often involves general anesthesia and requires an incision in a patient's neck to remove plaque from inside the artery wall. Carotid artery stenting is a minimally invasive treatment option for patients who require intervention to prevent a stroke and are at high risk for complications from traditional surgery. The procedure is performed by delivering a stent on a catheter through the femoral artery in the groin. The catheter is maneuvered through the patient's vasculature to the carotid artery. The stent, which is designed to prevent arterial plaque and debris from breaking off and blocking blood flow to the brain, is then expanded at the site of the blockage.
A rare diagnosis leads to successful treatment for patient with unusual vascular condition

A rare diagnosis leads to successful treatment for patient with unusual vascular condition

Ocean Medical Center receives major grant to support children with multiple health issues

Ocean Medical Center receives major grant to support children with multiple health issues

Herbal medicine for preventing, healing vascular diseases

Herbal medicine for preventing, healing vascular diseases

Combination of atrial fibrillation and carotid artery disease increases patient's risk of dementia

Combination of atrial fibrillation and carotid artery disease increases patient's risk of dementia

Hackensack Meridian Health offers cutting-edge treatment option for patients with carotid artery disease

Hackensack Meridian Health offers cutting-edge treatment option for patients with carotid artery disease

ESC recommendations on management of patients with peripheral arterial diseases published

ESC recommendations on management of patients with peripheral arterial diseases published

TCAR procedure offers potentially safer method for high-risk stroke patients

TCAR procedure offers potentially safer method for high-risk stroke patients

UT Southwestern's new operating suite integrates surgical and endovascular techniques in one space

UT Southwestern's new operating suite integrates surgical and endovascular techniques in one space

Study reveals no statistically significant difference between P-EPD and F-EPD devices

Study reveals no statistically significant difference between P-EPD and F-EPD devices

NYU Langone Medical Center researchers find that air pollution may pose significant stroke risk

NYU Langone Medical Center researchers find that air pollution may pose significant stroke risk

Jersey Coast Vascular Institute, Meridian Health partner to accept a wide range of insurances

Jersey Coast Vascular Institute, Meridian Health partner to accept a wide range of insurances

Inflating balloon inside artery after stent placement increases patients' risk of serious complications

Inflating balloon inside artery after stent placement increases patients' risk of serious complications

High-dose statins could have added benefit of reducing gum inflammation

High-dose statins could have added benefit of reducing gum inflammation

Snoring may indicate future health risks

Snoring may indicate future health risks

Tirofiban effectively prevents strokes in high risk patients

Tirofiban effectively prevents strokes in high risk patients

Patients with normal lipoprotein(a) levels may retain risk of atherosclerosis due to elevated LDL-P number

Patients with normal lipoprotein(a) levels may retain risk of atherosclerosis due to elevated LDL-P number

Positive results from Alnylam’s ALN-PCS Phase I trial on severe hypercholesterolemia

Positive results from Alnylam’s ALN-PCS Phase I trial on severe hypercholesterolemia

Emboshield Pro safer in patients ineligible for standard surgical treatment of CAD

Emboshield Pro safer in patients ineligible for standard surgical treatment of CAD

Positive preliminary results from Alnylam's Phase I ALN-PCS trial on severe hypercholesterolemia

Positive preliminary results from Alnylam's Phase I ALN-PCS trial on severe hypercholesterolemia

NYU Langone cardiovascular experts present new research findings at AHA 2011

NYU Langone cardiovascular experts present new research findings at AHA 2011